Notices and Announcements

Adjustment for CES HK Biotechnology Index


1 March 2019


As CStone Pharmaceuticals-B (02616.HK) satisfies the Fast Entry Rule of the CES HK Biotechnology Index, China Exchanges Services Company Limited and its index services agent, China Securities Index Company Limited, will make the following changes:




CES HK Biotechnology Index

CStone Pharmaceuticals-B (02616.HK)


The above adjustments will be implemented after the close of relevant exchange on 11 March 2019.


For more information, please contact:


China   Exchanges Services Company Limited




About CESC


CESC is a joint venture formed and equally owned by Hong Kong Exchanges and Clearing Limited, the Shanghai Stock Exchange and the Shenzhen Stock Exchange.  Its aim is to contribute to the development of China’s capital markets.  Registered and incorporated in Hong Kong, CESC was officially launched in September 2012 and commenced operations on 30 October.  CESC’s principal businesses include compiling cross-border indices based on products traded on the Hong Kong and Mainland securities markets, developing industry classifications for listed companies, and developing information standards and information products.  CESC also develops financial products to link the Mainland and Hong Kong markets with global investors.  China Securities Index Company Limited is commissioned to calculate, provide index maintenance and dissemination service for the CES indices.


For further information on CESC, please visit the website at